Detalhe da pesquisa
1.
Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission.
Biochemistry
; 57(5): 516-519, 2018 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29323879
2.
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.
J Infect Dis
; 213(11): 1743-51, 2016 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26908756
3.
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study.
J Infect Dis
; 214(5): 762-71, 2016 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27296848
4.
Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults.
Lancet Infect Dis
; 22(11): 1596-1605, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35963275
5.
Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers.
Hum Vaccin Immunother
; 16(1): 33-41, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31306084
6.
An open-label phase 1/2a trial of a genetically modified rodent malaria parasite for immunization against Plasmodium falciparum malaria.
Sci Transl Med
; 12(544)2020 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32434846
7.
Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.
Infect Immun
; 75(12): 5819-26, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17908809
8.
Vaccines to Accelerate Malaria Elimination and Eventual Eradication.
Cold Spring Harb Perspect Med
; 7(9)2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28490535
9.
Status of vaccine research and development of vaccines for malaria.
Vaccine
; 34(26): 2915-2920, 2016 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26993333
10.
PATH Malaria Vaccine Initiative (MVI): perspectives on the status of malaria vaccine development.
Hum Vaccin
; 6(1): 139-45, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20009524
11.
Building an effective malaria vaccine pipeline to address global needs.
Vaccine
; 33(52): 7538-43, 2015 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26469721
12.
Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward.
Vaccine
; 32(43): 5531-9, 2014 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25077422
13.
Malaria vaccine R&D in the Decade of Vaccines: breakthroughs, challenges and opportunities.
Vaccine
; 31 Suppl 2: B233-43, 2013 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23598488
14.
Aligning new interventions with developing country health systems: target product profiles, presentation, and clinical trial design.
Glob Public Health
; 7(9): 931-45, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22783872
15.
Effect of adjuvant on reactogenicity and long-term immunogenicity of the malaria Vaccine ICC-1132 in macaques.
Vaccine
; 23(41): 4935-43, 2005 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-15998554
16.
Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes.
Infect Immun
; 72(11): 6519-27, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15501783